Why the study?
Does constitutive GSK-3alpha/beta activity protect against chronic beta-adrenergic remodeling of the heart in mice?
Population
Knockin mice lacking the critical N-terminal serines, 21 of GSK-3alpha and 9 of GSK-3beta respectively, and…
Comparison
Chronic subcutaneous isoproterenol infusion over… vs Wild-type mice receiving the same chronic…
Design
Preclinical
Follow-up
14 days
Authors
Loading...
Constitutive GSK-3 activity attenuates ISO remodeling in mice; hypothesis-generating for human therapeutic targeting.
Does constitutive GSK-3alpha/beta activity protect against chronic beta-adrenergic remodeling of the heart in mice?
Expression of inactivation-resistant GSK-3alpha/beta protects against pathological hypertrophy induced by chronic adrenergic stimulation, suggesting a potential therapeutic target for preventing adverse cardiac remodeling.
Webb et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: